NCT00038584View on ClinicalTrials.gov

A Phase IB Study Of Oral SCH 66336 Preoperatively In Patients With Head And Neck Squamous Cell Cancer

PHASE1CompletedINTERVENTIONAL

Enrollment

37

Participants

Timeline

Start Date

June 30, 1999

Primary Completion Date

November 30, 2004

Study Completion Date

November 30, 2004

Conditions

Carcinoma, Squamous CellCancer of Head and Neck

Interventions

DRUG

SCH66336

Trial Locations (1)

77030

The University of Texas M. D. Anderson Cancer Center, Houston

Sponsors

Collaborators (1)

Schering-Plough

All Listed Sponsors

collaborator

Schering-Plough

INDUSTRY

lead

M.D. Anderson Cancer Center

OTHER